Our 2016 study demonstrated HER2 expression in retinoblastoma tumors (and its absence in normal ocular tissues) by multiple methods, including immunohistochemistry, flow cytometry, RT-PCR and western immunoblot [7], but not in situ hybridization. This evidence concerns the gene ERBB2 and retinoblastoma.